Cancer Management and Research
Volume 11, 2019 - Issue
Open access
134
Views
11
CrossRef citations to date
0
Altmetric
Original Research
Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China
Ruxu You1 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China
, Jinyu Liu2 Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China
, David Bin-Chia Wu3 School of Pharmacy, Monash University Malaysia, Kuala Selangor, Malaysia
, XinYu Qian4 Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
, Boxiang Lyu5 Machine Learning Department, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA
, Yu Zhang1 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China
& Nan Luo4 Saw Swee Hock School of Public Health, National University of Singapore, Singapore, SingaporeCorrespondence[email protected]
show all
Pages 10239-10248
|
Published online: 05 Dec 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.